Denosumab-associated osteonecrosis of the jaw: earlier onset after switch from zoledronic acid

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1920卷 / 1期
关键词：
D O I：
10.1007/s40278-022-21546-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [1] Osteonecrosis of the Jaw After Zoledronic Acid and Denosumab Treatment
    Fusco, Vittorio
    Galassi, Claudia
    Berruti, Alfredo
    Ciuffreda, Libero
    Ortega, Cinzia
    Ciccone, Giovannino
    Angeli, Alberto
    Bertetto, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : E521 - E522
  • [2] Osteonecrosis of the Jaw After Zoledronic Acid and Denosumab Treatment Reply
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) : E523 - E524
  • [3] Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
    Higuchi, Tomoko
    Soga, Yoshihiko
    Muro, Misato
    Kajizono, Makoto
    Kitamura, Yoshihisa
    Sendo, Toshiaki
    Sasaki, Akira
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2018, 125 (06): : 547 - 551
  • [4] Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid
    Borras-Blasco, J.
    Rosique-Robles, D.
    Giner-Marco, V.
    Galan-Brotons, A.
    Castera, E.
    Costa, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (06) : 651 - 654
  • [5] Denosumab/zoledronic acidMaxillary osteonecrosis of jaw: case report
    Reactions Weekly, 2022, 1931 (1) : 224 - 224
  • [6] Denosumab-associated osteonecrosis of the jaw affects osteoclast formation and differentiation: Pathological features of two cases
    Matsushita, Yuki
    Hayashida, Saki
    Morishita, Kota
    Sakamoto, Hiroshi
    Naruse, Tomofumi
    Sakamoto, Yuki
    Yamada, Shin-Ichi
    Yanamoto, Souichi
    Fujita, Shuichi
    Ikeda, Tohru
    Umeda, Masahiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (02) : 191 - 194
  • [7] Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab
    Fusco, Vittorio
    Bedogni, Alberto
    Campisi, Giuseppina
    SUPPORTIVE CARE IN CANCER, 2014, 22 (07) : 1737 - 1738
  • [8] Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab
    Vittorio Fusco
    Alberto Bedogni
    Giuseppina Campisi
    Supportive Care in Cancer, 2014, 22 : 1737 - 1738
  • [9] Denosumab/ibandronic acid/zoledronic acidMedication-related osteonecrosis of jaw: case report
    Reactions Weekly, 2021, 1867 (1) : 151 - 151
  • [10] Erratum to: Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab
    Vittorio Fusco
    Alberto Bedogni
    Giuseppina Campisi
    Supportive Care in Cancer, 2014, 22 (7) : 1739 - 1739
12345